Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting GABA receptors. Shows potential in the development of anticonvulsant and anxiolytic agents. Its spirocyclic structure with oxime functionality enhances binding selectivity and metabolic stability in central nervous system drugs. Investigated for improving cognitive function and neuroprotection in preclinical studies.